Grove Ventures

Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.

Nucleai Ltd. is a spatial biology company that has developed an AI-powered pathology platform focused on enhancing drug development and improving patient outcomes. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Nucleai's technology utilizes unique tissue datasets and machine learning algorithms to analyze biopsy samples and detect various cancers, including prostate, breast, and gastrointestinal diseases. The platform aims to improve the interpretation of pathology results, thereby increasing the efficacy of clinical trials and fostering better patient care. Nucleai collaborates with leading pharmaceutical companies, licensing its platform for internal use and participating in biomarker discovery projects. By transforming healthcare through artificial intelligence, Nucleai strives to enable researchers to identify novel biomarkers that predict therapeutic responses and enhance understanding of complex biological phenomena.

Deepchecks Ltd, based in Tel Aviv-Yafo, Israel, specializes in developing a machine learning monitoring platform that supervises the performance and stability of AI systems. The company offers an open-source testing framework designed to facilitate the evaluation of large language model (LLM) applications. By collecting and analyzing raw data, Deepchecks enables visibility into the transformations of this data, ensuring that machine learning pipelines are thoroughly monitored. This approach allows organizations to release high-quality LLM applications rapidly while maintaining rigorous testing standards, thereby addressing the complexities associated with LLM interactions.

Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.

Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.

Nucleai Ltd. is a spatial biology company that has developed an AI-powered pathology platform focused on enhancing drug development and improving patient outcomes. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Nucleai's technology utilizes unique tissue datasets and machine learning algorithms to analyze biopsy samples and detect various cancers, including prostate, breast, and gastrointestinal diseases. The platform aims to improve the interpretation of pathology results, thereby increasing the efficacy of clinical trials and fostering better patient care. Nucleai collaborates with leading pharmaceutical companies, licensing its platform for internal use and participating in biomarker discovery projects. By transforming healthcare through artificial intelligence, Nucleai strives to enable researchers to identify novel biomarkers that predict therapeutic responses and enhance understanding of complex biological phenomena.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service (SaaS) solutions. It is known for its RapidAPI Hub, the largest API hub globally, which allows over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from various leading companies. Rapid provides a comprehensive suite of APIs, including those for machine learning, SMS, email, payments, and food services. Additionally, the company offers RapidAPI Studio, a platform that streamlines the API development process by enabling developers to design, test, monitor, and publish APIs efficiently. For enterprise clients, RapidAPI Enterprise Hub provides a customizable solution for managing both internal and external APIs, enhancing connectivity and functionality for organizations. Founded in 2014, Rapid has established itself as a key player in the API ecosystem, particularly for modern developers.

Lumigo Ltd. operates a platform designed for monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and based in Tel Aviv, Israel, the platform leverages data analysis to understand the normal behavior of serverless applications, providing live visual maps and insights for developers. This functionality enables operations teams to trace requests not only through the serverless infrastructure but also across related services, such as databases and storage. By implementing distributed tracing, Lumigo offers end-to-end stack traces that include full HTTP payload data, allowing organizations to quickly address critical production issues without the need for extensive logging. The platform also enhances visibility and traceability, helping enterprises prevent service disruptions through actionable alerts based on user behavior analytics.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service (SaaS) solutions. It is known for its RapidAPI Hub, the largest API hub globally, which allows over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from various leading companies. Rapid provides a comprehensive suite of APIs, including those for machine learning, SMS, email, payments, and food services. Additionally, the company offers RapidAPI Studio, a platform that streamlines the API development process by enabling developers to design, test, monitor, and publish APIs efficiently. For enterprise clients, RapidAPI Enterprise Hub provides a customizable solution for managing both internal and external APIs, enhancing connectivity and functionality for organizations. Founded in 2014, Rapid has established itself as a key player in the API ecosystem, particularly for modern developers.

Teramount Ltd., founded in 2013 and based in Jerusalem, Israel, specializes in manufacturing the Photonic-Plug, a novel solution designed to connect optics to silicon in semiconductor manufacturing. This patent-pending technology facilitates integration with standard semiconductor processes and packaging, enabling fabless semiconductor companies to venture into silicon photonics while collaborating with traditional foundries and outsourced semiconductor assembly and test (OSAT) providers. The Photonic-Plug is engineered to enhance assembly tolerances, allowing for passive alignment and efficient volume packaging on standard CMOS assembly lines. This innovation significantly improves throughput and reduces costs, making it suitable for widespread deployment in data centers and various telecommunications applications.

Nucleai Ltd. is a spatial biology company that has developed an AI-powered pathology platform focused on enhancing drug development and improving patient outcomes. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Nucleai's technology utilizes unique tissue datasets and machine learning algorithms to analyze biopsy samples and detect various cancers, including prostate, breast, and gastrointestinal diseases. The platform aims to improve the interpretation of pathology results, thereby increasing the efficacy of clinical trials and fostering better patient care. Nucleai collaborates with leading pharmaceutical companies, licensing its platform for internal use and participating in biomarker discovery projects. By transforming healthcare through artificial intelligence, Nucleai strives to enable researchers to identify novel biomarkers that predict therapeutic responses and enhance understanding of complex biological phenomena.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service (SaaS) solutions. It is known for its RapidAPI Hub, the largest API hub globally, which allows over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from various leading companies. Rapid provides a comprehensive suite of APIs, including those for machine learning, SMS, email, payments, and food services. Additionally, the company offers RapidAPI Studio, a platform that streamlines the API development process by enabling developers to design, test, monitor, and publish APIs efficiently. For enterprise clients, RapidAPI Enterprise Hub provides a customizable solution for managing both internal and external APIs, enhancing connectivity and functionality for organizations. Founded in 2014, Rapid has established itself as a key player in the API ecosystem, particularly for modern developers.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service (SaaS) solutions. It is known for its RapidAPI Hub, the largest API hub globally, which allows over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from various leading companies. Rapid provides a comprehensive suite of APIs, including those for machine learning, SMS, email, payments, and food services. Additionally, the company offers RapidAPI Studio, a platform that streamlines the API development process by enabling developers to design, test, monitor, and publish APIs efficiently. For enterprise clients, RapidAPI Enterprise Hub provides a customizable solution for managing both internal and external APIs, enhancing connectivity and functionality for organizations. Founded in 2014, Rapid has established itself as a key player in the API ecosystem, particularly for modern developers.

Lumigo Ltd. operates a platform designed for monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and based in Tel Aviv, Israel, the platform leverages data analysis to understand the normal behavior of serverless applications, providing live visual maps and insights for developers. This functionality enables operations teams to trace requests not only through the serverless infrastructure but also across related services, such as databases and storage. By implementing distributed tracing, Lumigo offers end-to-end stack traces that include full HTTP payload data, allowing organizations to quickly address critical production issues without the need for extensive logging. The platform also enhances visibility and traceability, helping enterprises prevent service disruptions through actionable alerts based on user behavior analytics.

Nucleai Ltd. is a spatial biology company that has developed an AI-powered pathology platform focused on enhancing drug development and improving patient outcomes. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Nucleai's technology utilizes unique tissue datasets and machine learning algorithms to analyze biopsy samples and detect various cancers, including prostate, breast, and gastrointestinal diseases. The platform aims to improve the interpretation of pathology results, thereby increasing the efficacy of clinical trials and fostering better patient care. Nucleai collaborates with leading pharmaceutical companies, licensing its platform for internal use and participating in biomarker discovery projects. By transforming healthcare through artificial intelligence, Nucleai strives to enable researchers to identify novel biomarkers that predict therapeutic responses and enhance understanding of complex biological phenomena.